| 구조 |
화학 이름 |
CAS |
MF |
 |
LY2584702 |
1082949-67-4 |
C21H19F4N7 |
 |
KX2-391 |
897016-82-9 |
C26H29N3O3 |
 |
RG-7388 |
1229705-06-9 |
C31H29Cl2F2N3O4 |
 |
ML 133 Hydrochloride |
1222781-70-5 |
C19H20ClNO |
 |
Voreloxin |
175414-77-4 |
C18H19N5O4S |
 |
GSK2656157 |
1337532-29-2 |
C23H21FN6O |
![6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one](/CAS/20150408/GIF/1286739-19-2.gif) |
6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one |
1286739-19-2 |
C29H28ClN7OS |
 |
IPA-3 |
42521-82-4 |
C20H14O2S2 |
 |
NSC319726 |
71555-25-4 |
C11H14N4S |
 |
Carbonic Anhydrase IX/XII Inhibitor II(U-104) |
178606-66-1 |
C13H12FN3O3S |
 |
A 205804 |
251992-66-2 |
C15H12N2OS2 |
![2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one](/CAS/GIF/1234480-50-2.gif) |
2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one |
1234480-50-2 |
C26H30N6O3 |
![5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine](/CAS/GIF/865362-74-9.gif) |
5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine |
865362-74-9 |
C18H13N7 |
 |
JNJ 1661010 |
681136-29-8 |
C19H19N5OS |
 |
TAK875 |
1374598-80-7 |
C58H66O15S2 |
![7-Methyl-5-[(3-piperazin-1-ylMethyl)-1,2,4-oxadiazol-5-yl-]-2-[4-(trifluoroMethoxy)benzyl]-2,3-dihydro-1H-isoindol-1-one Methanesulphonate](/CAS/20150408/GIF/802904-66-1.gif) |
7-Methyl-5-[(3-piperazin-1-ylMethyl)-1,2,4-oxadiazol-5-yl-]-2-[4-(trifluoroMethoxy)benzyl]-2,3-dihydro-1H-isoindol-1-one Methanesulphonate |
802904-66-1 |
C19H17ClN2O3S |
 |
GABAPENTIN-D6 HYDROCHLORIDE |
60142-95-2 |
C9H12ClD6NO2 |
 |
구0060648 |
881375-00-4 |
C33H34N4O4S |
![2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone](/CAS/GIF/571203-78-6.gif) |
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone |
571203-78-6 |
C30H31ClN4O4 |
 |
CGS 21680A |
124431-80-7 |
C23H30ClN7O6 |
 |
DBeQ |
177355-84-9 |
C22H20N4 |
 |
GW791343 HCl |
309712-55-8 |
C20H27Cl3F2N4O |
 |
AZD 9668 |
848141-11-7 |
C25H22F3N5O4S |
 |
Verdinexor (KPT-335) |
1392136-43-4 |
C18H12F6N6O |
 |
Nodinitib-1 |
799264-47-4 |
C14H13N3O2S |
 |
Teneligliptin Hydrobromide |
906093-29-6 |
C22H31BrN6OS |
 |
KPT-330 |
1393477-72-9 |
C17H11F6N7O |
![1-Methyl-N-[2-methyl-4-[2-(2-methylphenyl)diazenyl]phenyl-1H-pyrazole-5-carboxamide](/CAS/20150408/GIF/301326-22-7.gif) |
1-Methyl-N-[2-methyl-4-[2-(2-methylphenyl)diazenyl]phenyl-1H-pyrazole-5-carboxamide |
301326-22-7 |
C19H19N5O |
 |
CP 91149 |
186392-40-5 |
C21H21ClN3O3 |
 |
Raf265 derivative |
1942849-27-5 |
C23H14F6N6O |
 |
Ferrostatin-1 (Fer-1) |
347174-05-4 |
C15H22N2O2 |
![4-[[4,5-Bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-2-piperazinone](/CAS2/GIF/890090-75-2.gif) |
4-[[4,5-Bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-2-piperazinone |
890090-75-2 |
C30H30Cl2N4O4 |
 |
IEM 1754 dihydrobroMide |
162831-31-4 |
C16H32Br2N2 |
 |
GDC-0152 |
873652-48-3 |
C25H34N6O3S |
![2-Cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide](/CAS/GIF/304896-28-4.gif) |
2-Cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide |
304896-28-4 |
C23H13Cl2N3O2 |
 |
Nutlin-3b |
675576-97-3 |
C30H30Cl2N4O4 |
 |
HO-3867 |
1172133-28-6 |
C28H30F2N2O2 |
 |
PYR 41 |
418805-02-4 |
C17H13N3O7 |
 |
BAM7 |
331244-89-4 |
C21H19N5O2S |
 |
NSC697923 |
343351-67-7 |
C11H9NO5S |
 |
BV6 |
1001600-56-1 |
C70H96N10O8 |
 |
BAF-312(SiponiMod) |
1230487-00-9 |
C29H35F3N2O3 |
 |
4-(4-Methyl-1-piperazinyl)-7-nitrobenzofurazane 3-oxide |
58131-57-0 |
C11H13N5O4 |
 |
Ki16198 |
355025-13-7 |
C24H25ClN2O5S |
 |
ISRIB (trans-isoMer) |
1597403-47-8 |
C22H24Cl2N2O4 |
 |
JNK-IN-8 |
1410880-22-6 |
C29H29N7O2 |
 |
Edoxaban (tosylate Monohydrate) |
1229194-11-9 |
C31H38ClN7O7S2 |
 |
YH239-EE |
1364488-67-4 |
C25H27Cl2N3O4 |
 |
3-(2,4-Dichloro-5-methoxyphenyl)-2,3-dihydro-2-thioxo-4(1H)-quinazolinone |
338967-87-6 |
C15H10Cl2N2O2S |
 |
PF 543 |
1415562-82-1 |
C27H31NO4S |
 |
WZ4003 |
1214265-58-3 |
C25H29ClN6O3 |
 |
SH-4-54 |
1456632-40-8 |
C29H27F5N2O5S |
 |
NH125 |
278603-08-0 |
C27H45N2.I |
 |
H-89 DIHYDROCHLORIDE HYDRATE |
130964-39-5 |
C20H20BrN3O2S.2ClH.H2O |
 |
AKT키나제억제제 |
842148-40-7 |
C16H19N7O3 |
![L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoaMino]-, (Hydrochloride) (1:2)](/CAS/GIF/685898-44-6.gif) |
L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoaMino]-, (Hydrochloride) (1:2) |
685898-44-6 |
C13H19Cl3N2O3 |
 |
RGFP 109 |
1215493-56-3 |
C20H25N3O2 |
 |
Cabotegravir (GSK744, GSK1265744) |
1051375-10-0 |
C19H17F2N3O5 |
 |
BRD4770 |
1374601-40-7 |
C25H23N3O3 |
 |
VER-49009 |
940289-57-6 |
C19H18ClN3O4 |
 |
OG-L002 |
1357302-64-7 |
C15H15NO |
 |
WAY100635 |
1092679-51-0 |
C29H38N4O6 |
 |
LDC000067 |
1073485-20-7 |
C18H18N4O3S |
 |
WS3 |
1421227-52-2 |
C28H30F3N7O3 |
 |
LMK-235 |
1418033-25-6 |
C15H22N2O4 |
 |
Cathepsin Inhibitor 1 |
225120-65-0 |
C20H24ClN5O2 |
 |
Deltarasin |
1440898-61-2 |
C40H37N5O |
 |
GSK-2110183C |
1047644-62-1 |
C18H17Cl2FN4OS |
 |
BS-181 HCl |
1397219-81-6 |
C22H33ClN6 |
 |
RGFP966 |
1396841-57-8 |
C21H19FN4O |
 |
ReModelin hydrobroMide |
1622921-15-6 |
C15H15BrN4S |
 |
위키4 |
838818-26-1 |
C29H23N5O3S |
 |
FTI 277 HYDROCHLORIDE |
180977-34-8 |
C22H30ClN3O3S2 |
 |
PD 151746 |
179461-52-0 |
C11H8FNO2S |
 |
LB 42708 |
226929-39-1 |
C30H27BrN4O2 |
 |
BI-97C1 |
1228108-65-3 |
C42H40N2O8 |
 |
Tubastatin-A |
1252003-15-8 |
C20H21N3O2 |
 |
PI-1840 |
1401223-22-0 |
C22H26N4O3 |
 |
SCR7 |
1533426-72-0 |
C18H14N4OS |
 |
MI-3 (Menin-MLL Inhibitor) |
1271738-59-0 |
C18H25N5S2 |
 |
CPI-203 |
1446144-04-2 |
C19H18ClN5OS |
 |
LFM-A13 |
244240-24-2 |
C11H8Br2N2O2 |
 |
ZM 39923 HCl |
1021868-92-7 |
C23H26ClNO |
 |
BMX-IN-1 |
1431525-23-3 |
C29H24N4O4S |
 |
GSK1324726A (I-BET726) |
1300031-52-0 |
C25H23ClN2O3 |
 |
PFI3 |
1819363-80-8 |
C19H19N3O2 |
 |
PFI-2 |
1627676-59-8 |
C23H25F4N3O3S |
 |
MG149 |
1243583-85-8 |
C22H28O3 |
 |
ARQ 621 |
1095253-39-6 |
C28H24Cl2FN5O2 |
 |
CH5138303 |
959763-06-5 |
C19H18ClN5O2S |
 |
CAY10683 (SantacruzaMate A) |
1477949-42-0 |
C15H22N2O3 |
 |
Dizocilpine |
77086-21-6 |
C16H15N |
 |
SBE 13 hydrochloride |
1052532-15-6 |
C24H28Cl2N2O4 |
 |
GZD824 |
1421783-64-3 |
C31H35F3N6O7S2 |
 |
Defactinib |
1073154-85-4 |
C20H21F3N8O3S |
 |
Triapine |
200933-27-3 |
C7H9N5S |
 |
BIX 01294 |
1392399-03-9 |
C28H41Cl3N6O2 |
 |
K-Ras inhibitor |
1469338-01-9 |
C20H30ClN3O2S3 |
 |
LDN-214117 |
1627503-67-6 |
C25H29N3O3 |
 |
GSK-LSD1 |
1431368-48-7 |
C14H20N2 |